Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.9019
+0.0319 (3.67%)
At close: May 29, 2025, 4:00 PM
0.9200
+0.0181 (2.01%)
After-hours: May 29, 2025, 4:55 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Precision Oncology Therapies
7.00M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
7.00M